Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

34
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
34
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

33
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
33
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

52
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
52
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

23
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
23
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

25
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
25
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

1.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanistic insights into the early life stage microbiota of silver pompano (<i>Trachinotus blochii</i>).

Frontiers in microbiology·2024
Same author

Replacement of failed items in a two commodity retrial queueing-inventory system with multi-component demand and vacation interruption.

Heliyon·2024
Same author

MRI Evidence of Altered Callosal Sodium in Mild Traumatic Brain Injury.

AJNR. American journal of neuroradiology·2018
Same author

Antiinflammatory evaluation of leaves of Plumeria acuminata.

BMC complementary and alternative medicine·2006
Same author

Antioxidant and antimicrobial activities of Bauhinia racemosa L. stem bark.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2005
Same author

Anti-inflammatory, analgesic and antipyretic effects of methanol extract from Bauhinia racemosa stem bark in animal models.

Journal of ethnopharmacology·2005

Related Experiment Video

Updated: Sep 14, 2025

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

1.8K

Multi-cascaded heart disease prediction using hybrid deep learning and optimization techniques.

K Lakshmanan1, P Gomathi2

  • 1Principal, Sri Durgadevi Polytechnic College, Kavaraipettai, Gummidipoondi, Thiruvellore, Tamil Nadu, India.

Computer Methods in Biomechanics and Biomedical Engineering
|July 24, 2025
PubMed
Summary

A new deep learning model accurately predicts heart disease using advanced data processing and feature selection. This novel approach achieves 96.65% accuracy, offering a significant advancement in early cardiac condition detection.

Keywords:
Heart disease predictionmulti cascaded deep learning networkmutated iteration-based fire hawk with coyote optimizationoptimal weighted features

More Related Videos

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K

Related Experiment Videos

Last Updated: Sep 14, 2025

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

1.8K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K

Area of Science:

  • Artificial Intelligence
  • Cardiology
  • Machine Learning

Background:

  • Heart disease remains a leading cause of mortality worldwide.
  • Accurate and early prediction is crucial for effective patient management.
  • Existing prediction models often face challenges with data complexity and feature selection.

Purpose of the Study:

  • To propose a novel deep learning model for enhanced heart disease prediction.
  • To introduce an optimized feature selection method for improved model performance.
  • To validate the model's efficacy using a benchmark dataset.

Main Methods:

  • Data preprocessing using NaN fill and data normalization.
  • Optimal weighted feature selection via Mutated Iteration-based Fire Hawk with Coyote Optimization (MI-FHCO).
  • Heart disease prediction using a Multi-Cascaded Deep Learning Network (MDLNet).

Main Results:

  • The proposed deep learning model achieved a high accuracy rate of 96.65% on dataset 4.
  • The MI-FHCO algorithm effectively identified optimal features for prediction.
  • The MDLNet demonstrated superior performance in heart disease classification.

Conclusions:

  • The novel deep learning approach offers a highly accurate method for heart disease prediction.
  • The MI-FHCO feature selection technique enhances model specificity and sensitivity.
  • This model shows significant potential for clinical application in early heart disease detection.